American Regent Introduces Fda-Approved Epinephrine Injection, Usp
29 Oct 2024 //
PR NEWSWIRE
American Regent Introduces FDA-Approved Sodium Phosphates Injection
02 Jul 2024 //
PR NEWSWIRE
Enforcement Report - Week of May 29, 2024
29 May 2024 //
FDA
American Regent`s Generic Potassium Phosphate Receives Approval in the U.S.
02 Oct 2023 //
FDA
American Regent Announces Results From Phase 3 HEART-FID Trial with INJECTAFER®
26 Aug 2023 //
BUSINESSWIRE
HBT Labs, Inc. to Join American Regent, Inc.
17 Aug 2022 //
PRNEWSWIRE
American Regent Launches a New Vial Presentation
30 Jun 2022 //
PRNEWSWIRE
American Regent launches Selenious Acid Injection, USP in single-dose vial.
31 Mar 2022 //
PRNEWSWIRE
American Regent introduces FDA-approved Vasopressin Injection, USP
03 Feb 2022 //
PRNEWSWIRE
Vifor, American Regent announce settlement of Injectafer patent litigation
19 Dec 2021 //
BUSINESSWIRE
American Regent Launches Multrys™ (trace elements injection 4*, USP)
02 Sep 2021 //
PRNEWSWIRE
American Regent Introduces Estradiol Valerate Injection, USP; AO Rated
02 Jun 2020 //
PRNEWSWIRE